Recent advances in ureteral stents

Current Opinion in Urology

Volumn 18, Issue 2, 2008, Pages 241-246

  Yachia, Daniel ^a,b,c  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b HILLEL YAFFE MEDICAL CENTER   (Israel)

^c NONE   (Israel)

Author keywords

Self expanding stents; Stent based drug delivery; Ureteral stents

Indexed keywords

BIOMATERIAL; POLYMER;

CYSTOSCOPE; EXTRACORPOREAL LITHOTRIPSY; HUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STONE DISSOLUTION; SURGICAL TECHNIQUE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; URETER STENT; URETER STRICTURE; URETEROSCOPE; URINARY TRACT OBSTRUCTION;

COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; HUMANS; STENTS; URETERAL OBSTRUCTION; URETEROSCOPY;

EID: 39849103273     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3282f46d81     Document Type: Review

References (49)

1. Hamill TM, Gilmore BF, Jones DS, Gorman SP. Strategies for the development of the urinary catheter. Expert Rev Med Dev 2007; 4:215-225.
2. Laube N, Kleinen L, Bradenahl J, Meissner A. Diamond-like carbon coatings on ureteral stents - a new strategy for decreasing the formation of crystalline bacterial biofilms? J Urol 2007; 177:1923-1927. This paper describes the importance of surface characteristicts of ureteral stents left indwelling for long periods.
3. Koseoglu H, Aslan G, Esen N, et al. Ultrastructural stages of biofilm development of Escherichia coli on urethral catheters and effects of antibiotics on biofilm formation. Urology 2006; 68:942-946. This paper describes the mechanism of the biofilm formation on urinary catheters.
4. Cappelli G, Ricardi M, Ravera F, et al. Biofilm on artificial surfaces. Contrib Nephrol 2007; 154:61-71.
5. Kajzer W, Chrzanowski W, Marciniak J. Corrosion resistance of Cr-Ni-Mo steel intended for urological stents. Int J Microstructure and Materials Properties 2007; 2:188-201.
6. Moseler M, Gumbsch P, Casiraghi C, et al. The ultrasmoothness of diamond-like carbon surfaces. Science 2005; 309:1545-1548.
7. Cadieux PA, Chew BH, Knudsen BE, et al. Triclosan loaded ureteral stents decrease Proteus Mirabilis 296 infection in a rabbit urinary tract infection model. J Urol 2006; 175:2331-2335. This is a comprehensive study which evaluates the effectiveness of an agent (used from toothpaste to suture materials) in preventing biofilm formation and encrustation on ureteral stents.
8. Nabi G, Cook J, N'Dow J, McClinton S. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. BMJ 2007; 334:572.
9. El-Assmy A, El-Nahas AR, Sheir KZ. Is preshock wave lithotripsy stenting necessary for ureteral stones with moderate or severe hydronephrosis? J Urol 2006; 176:2059-2062. The paper studies the role of a preprocedural double-J insertion in SWL.
10. Sawfat A, Bissada A, Kumar U, et al. Holmium laser ureterolithotripsy: when is a stent indicated [abstract]. Urology 2006; 68 (supplement 5A):281.
11. Herndon CDA, Viamonte L, Joseph DB. Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting? J Ped Urol 2006; 2:290-293.
12. Castagnetti M, Cimador M, Sergio M, DeGrazia E. DoubleJ stent insertion across vesicoureteral junction - is it a valuable initial approach in neonates and infants with severe primary nonrefluxing megaureter? Urology 2006; 68:870-876.
13. Sigman DB, Del Pizzo JJ, Sklar GN. Endoscopic retrograde stenting for allograft hydronephrosis. J Endourol 1999; 13:21-25.
14. Gerrard ER Jr, Burns JR, Young CJ, et al. Retrograde stenting for obstruction of the renal transplant ureter. Urology 2005; 66:256-260.
15. Agarwal G, Palagiri AV, Bouillier JA, Cummings JM. Endoscopic management of ureteral complications following renal transplantation. Transplantation Proc 2006; 38:2921-2922. The paper describes the simple approach of retrograde double-J stent insertion in the treatment of ureteral stictures after renal transplantation.
16. White MA, Kepros JP, Zuckerman LJ. Bilateral partial ureteropelvic junction disruption after blunt trauma treated with indwelling ureteral stents. Urology 2007; 69:384.e15-384.e17.
17. Chung SY, Stein RJ, Landsittel D, et al. 15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents. J Urol 2004; 172:592-595.
18. Ganatra AM, Loughling KM. The management of malignant ureteral obstruction treated with ureteral stents. J Urol 2006; 174:2125-2128.
19. Kazuya O, Naruaki T, Tatsuo K, Noriyuki K. Clinical characteristics of the double-J ureteral stent placement in patients with upper urinary tract obstruction (Japanese). Clin Urol 2000; 54 (9):697-701.
20. Hafron J, Ost MC, Jit Tan B, et al. Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. Urology 2006; 68:911-915. An excellent paper showing the importance of intraluminal flow through ureteral stents in malignant obstructions.
21. Hruby GW, Ames CD, Yan Y, et al. Correlation of ureteric length with anthropometric variables of surface body habitus. BJU Int 2007; 99:1119-1122. An important paper describing the way for simplifying the calculations for choosing the accurate length double-J stent for each patient.
22. Palmer JS, Palmer LS. A simple and reliable formula for determining the proper JJ stent length in the pediatric patient: Age 10 [abstract]. Urology 2007; 70(supplement 3A):264.
23. Osamu M, Kazumi S, Yasunobu S, et al. Placement of J-J ureteric stents using the flexible cystoscope (Japanese). J Clin Urol 1999; 53 (6):417-420.
24. Richter F, Irwin RJ, Watson R, Lang E. Endourologic management of malignant ureteral strictures. J Endourol 2000; 14:583-587.
25. Geavlete P, Soroiu D, Nita G. Antegrade flexible ureteroscopy in lower ureteral stenosis [abstract]. Urology 2006; 68 (Supplement 5A):223.
26. Macri A, Magno C, Certo A, et al. Combined antegrade and retrograde ureteral stenting: the rendezvous technique. Clin Radiol 2005; 60:257-260.
27. Nagele U, Anastasiadis AG, Amend B, et al. Steerable antegrade stenting: a new trick of the trade. Int Braz J Urol 2007; 33:389-394.
28. Candela JV, Bellman GC. Ureteral stents impact of diameter and composition on patient symptoms. J Endourol 1997; 11:45-47.
29. Rane A, Saleemi A, Cahill D, et al. Have stent-related symptoms anything to do with placement technique? J Endourol 2001; 15:741-745.
30. Al-Kandari AM, Al-Shaiji TF, Shaaban H, et al. Effects of proximal and distal ends of double-J ureteral stent position on postprocedural symptoms and quality of life: a randomized clinical trial. J Endourol 2007; 21:698-702.
31. Deliveliotis C, Christofos M, Gougousis E, et al. Is there a role for alpha1-blockers in treating double-J stent-related symptoms? Urology 2006; 67:35-39.
32. L'Esperance JO, Rickner T, Hoenig D, et al. Ureteral expanding stent: a new device for urolithiasis. J Endourol 2007; 21:533-537. This paper describes a new ureteral stent design for helping expulsion or removal of small ureterolithiasis. Is this a gimmick, or an important new tool which has to be proved in further studies?
33. Kulkarni R, Bellamy E. Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction: 4-year experience. J Urol 2001; 166:1750-1754.
34. Klarskov P, Nordling J, Nielsen JB. Experience with Memokath ureteral stent. Scand J Urol Nephrol 2005; 39:169-172.
35. Siddique KA, Zammit P, Bafaloukas N, et al. Repositioning and removal of an intra-renal migrated ureteric Memokath stent. Urol Int 2006; 77:297-300.
36. Blaschko SD, Deane LE, Krebs A, et al. In-vivo evaluation of flow characteristics of novel metal ureteral stent. J Endourol 2007; 21:780-783. This paper describes the different flow characteristics of ureteral stents, including a new metal coil.
37. Monga M, Pedro RN, Kriedberg C, Hendlin K. Wire-based ureteral stents: Impact on tensile strength and compression. Urology 2007; 70 (supplement 3A):52.
38. Milroy EJ, Chapple CR, Cooper JE, et al. A new treatment for urethral strictures. Lancet 1999; 1:1424-1427.
39. Oesterling JE, Kaplan SA, Epstein HB, et al. The North American experience with the Urolume endoprosthesis as a treatment for benign prostatic hyperplasia: long term results. The North American Urolume Study Group. Urology 1994; 44:353-362.
40. Glass JM, Williams G. Is there a role for epithelizing stents in the treatment of BPH? In: Yachia D, Paterson PJ, editors. Stenting the urinary tract. 2nd ed. London: Martin Dunitz; 2004399-404.
41. Liatsikos EN, Kagadis GC, Barbalias GA, Siablis D. Ureteral metal stents: a tale or a tool? J Endourol 2005; 19:934-939.
42. Norio M, Shiro B. Metallic stents as a new therapeutic procedure for urinary tract obstruction (Japanese). J Japan Surg Soc 2003; 104:567-570.
43. Li X, He Z, Yuan J, et al. Long-term results of permanent metallic stent implantation in the treatment of benign upper urinary tract occlusion. Int J Urol 2007; 14:693-698.
44. Mallikarjuna C, Suri Babu A, Vijaya Kumar K. Permanent metallic stents in ureteric strictures [abstract]. Urology 2006; 68 (supplement 5A):224-225.
45. Grube E, Buellesfeld L. Paclitaxel-eluting stents: current clinical experience. Am J Cardiovasc Drugs 2004; 4:355-360.
46. Liatsikos EN, Karnabatidis D, Kagadis GC, et al. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study. Eur Urol 2007; 51:217-223. A paper describing in a comprehensive way the possibility of using drug-eluting metal stents - from coronary stents origin - for preventing stent-induced restenosis in the ureter.
47. Zilberman M, Eberhart RC. Drug-eluting bioresorbable stents for various applications. Annu Rev Biomed Eng 2006; 8:153-180. An excellent and comprehensive review of bioresorbable polymer based drug delivery stents, bringing together the most recent studies on this subject.
48. Kemppainen E, Talja M, Riihela M, et al. A bioresorbable urethral stent. An experimental study. Urol Res 1993; 21:235-238.
49. Farokhzad OC, Dimitrakov JD, Karp JM, et al. Drug delivery systems in urology - getting "smarter". Urology 2006; 68:463-469. An excellent and comprehensive paper on a new generation of polymers having the characteristics of shape memory metals combined with biodegradation possibilities. Such materials have the potential of becoming the core of the future stent in the urinary tract.